Literatur
- 1
Albrecht H, Hoffmann C, Degen O. et al .
Highly active antiretroviral therapy significantly
improves the prognosis of patients with HIV-associated progressive
multifocal leukoencephalopathy.
AIDS.
1998;
12
1149-1154
- 2
Anduze-Faris B M, Fillet A M, Gozlan J. et al .
Induction and maintenance
therapy of cytomegalovirus central nervous system infection in HIV-infected patients.
AIDS.
2000;
31
517-524
- 3
Barchiesi F, Schimizzi A M, Caselli F. et al .
Interactions between triazoles and amphotericin
B against Cryptococcus neoformans.
Antimicrob Agents Chemother.
2000;
44
2435-2441
- 4
Blick G, Garton T, Hopkins U, LaGravinese L.
Successful use of cidofovir
in treating AIDS-related cytomegalovirus retinitis, encephalitis,
and esophagitis.
J Acquir Immune Defic Syndr Hum Retrovirol.
1997;
15
84-85
- 5
Brown M, Scarborough M, Brink N, Manji H, Miller R.
Varicella
zoster virus-associated neurological disease in HIV-infected patients.
Int
J STD AIDS.
2001;
12
79-83
- 6
Canessa A, Del Bono V, De Leo P, Piersantelli N, Terragna A.
Cotrimoxazole therapy
of toxoplasma gondii encephalitis in AIDS patients.
Eur
J Clin Microbiol Infect Dis.
1992;
11
125-130
- 7
Casado J L, Quereda C, Oliva J. et al .
Candidal meningitis in HIV-infected patients:
Analysis of 14 cases.
Clin Infect Dis.
1997;
25
673-676
- 8
Chamberlain M C, Kormanik P A.
AIDS-related
central nervous system lymphomas.
J Neurooncol.
1999;
43
269-276
- 9
Chirgwin K, Hafner R, Leport C. et al .
Randomized phase II trial of atovaquone
with pyrimethamine or sulfadiazine for treatment of toxoplasmic
encephalitis in patients with acquired immunodeficiency syndrome:
ACTG 237/ANRS 039 Study.
Clin Infect Dis.
2002;
34
1243-1250
- 10
Cinque P, Pierotti C, Viganò M G. et al .
The good and evil of HAART
in HIV-related progressive multifocal leukoencephalopathy.
J
Neurovirol.
2001;
7
358-364
- 11
Coleman J M, Hogg G G, Rosenfeld J V, Waterski D.
Invasive
central nervous system aspergillosis cure with with liposomal amphotericin
B, itraconazole and radical surgery - case report and review
of the literature.
Neurosurgery.
1995;
36
858-856
- 12
Dannemann B, McCutchan J A, Israelski D. et al .
Treatment of toxoplasmic encephalitis
in patients with AIDS: a randomized trial comparing pyrimethamin
plus clindamycin to pyrimethamin plus sulfadiazine.
Ann
Intern Med.
1992;
116
33-43
- 13
Davidson P T, Le H Q.
Drug treatment
of tuberculosis-1992.
Drugs.
1992;
43
651-673
- 14
De Luca A, Giancola M L, Ammassari A. et al .
Cidofovir added to HAART
improves virological and clinical outcome in AIDS-associated progressive multifocal
leukoencephalopathy.
AIDS.
2000;
14
117-121
- 15
Denning D W, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M,
Lode H.
Efficacy
and safety of voriconazole in the treatment of acute invasive aspergillosis.
Clin
Infect Dis.
2002;
34
563-571
- 16
Flor A, Capdevila J A, Martin N. et al .
Nontuberculous mycobacterial meningitis:
report of two cases and review.
Clin Infect Dis.
1996;
23
1266-1273
- 17
Hoffmann C, Tabrizian S, Wolf E. et al .
Survival of AIDS patients with primary
central nervous system lymphoma is dramatically improved by HAART-induced
immune recovery.
AIDS.
2001;
15
2119-2127
- 18
Jones N, Khoosal M, Louw M, Karstaedt A.
Nocardial infection as a complication of
HIV in South Africa.
J Infect.
2000;
41
232-239
- 19
Jacobson J M, Hafner R, Remington J. et al .
Dose-escalation, phase I/II study
of azithromycin and pyrimethamine for the treatment of toxoplasmic
encephalitis in AIDS.
AIDS.
2001;
15
583-589
- 20
Katlama C, De Wit S, O’Doherty E. and ENTA Study Group .
Treatment of toxoplasmic
encephalitis in AIDS: a randomised European trial comparing pyrimethamine-clindamycin
to pyrimethamine-sulfadiazine.
Clin Infect Dis.
1996;
22
268-275
- 21
Komanduri K, Feinberg J, Hutchins R. et al .
Loss of cytomegalovirus-specific CD4+ T
cell responses in human immunodeficiency virus type 1-infected patients
with high CD4+ T cell counts and recurrent retinitits.
J
Infect Dis.
2001;
183
1285-1289
- 22
Liebeskind D S, Ostrzega N, Wasterlain C G, Buttner E A.
Neurologic
manifestations of disseminated infection with Mycobacterium abscessus.
Neurology.
2001;
56
810-813
- 23
McGrath N, Anderson N E, Croxson M C, Powell K F.
Herpes
simplex encephalitis treated with acyclovir: diagnosis and long
term outcome.
J Neurol Neurosurg Psychiatr.
1997;
63
321-326
- 24
Mocroft A, Katlama C, Johnson A M. et al .
AIDS across Europe, 1994 - 98:
the EuroSIDA study.
Lancet.
2000;
356
291-296
- 25
Nwokolo N C, Fisher M, Gazzard B G, Nelson M R.
Cessation of
secondary prophylaxis in patients with cryptococcosis.
AIDS.
2001;
15
1438-1439
- 26
Rodriguez-Arrondo F, Aguirrebengoa K, De Arce A. et al .
Candidal meningitis in HIV-infected patients:
treatment with fluconazole.
Scand J Infect Dis.
1998;
30
417-418
- 27
Rollot F, Bossi P, Tubiano R. et al .
Discontinuation of secondary prophylaxis against
cryptococcosis in patients with AIDS receiving highly active antiretroviral
therapy.
AIDS.
2001;
15
1448-1449
- 28
Saag M S, Graybill R J, Larsen R A. et al .
Practice guidelines for
the management of cryptococcal disease. Infectious Diseases Society
of America.
Clin Infect Dis.
2000;
30
710-718
- 29
Sadler M, Morris-Jones S, Nelson M, Gazzard B G.
Successful
treatment of cytomegalovirus encephalitis in an AIDS patient using
cidofovir.
AIDS.
1997;
11
1293-1294
- 30
Sanchez-Portocarrero J, Perez-Cecilia E, Romero-Vivas J.
Infection
of the central nervous system by Mycobacterium tuberculosis in patients
infected with human immunodeficiency virus (the new neurotuberculosis).
Infection.
1999;
27
313-317
- 31
Schiff D, Rosenblum M K.
Herpes simplex
encephalitis (HSE) and the immunocompromised: A clinical and autopsy
study of HSE in the settings of cancer and human immunodeficiency
virus-type 1 infection.
Hum Pathol.
1998;
29
215-222
- 32
Soriano V, Dona C, Rodriguez-Rosado R, Barreiro P, Gonzalez-Lahoz J.
Discontinuation
of secondary prophylaxis for opportunistic infections in HIV-infected
patients receiving highly active antiretroviral therapy.
AIDS.
2000;
14
383-386
- 33
Stoll M, Behrens G MN, Schmidt R E.
Immunrekonstitutionssyndrom. Ein neues Krankheitsbild
bei HIV-Infizierten unter wirksamer antiretroviraler Therapie.
Dtsch
Med Wochenschr.
2001;
126
1017-1022
- 34
Weber T, Klapper P E, Cleator G. et al .
Polymerase chain reaction for detection
of JC virus DNA in cerebrospinal fluid: a quality control study.
European Union concerted action on viral meningitis and encephalitis.
J
Virol Methods.
1997;
69
231-237
Dr. Thorsten Rosenkranz
Allgemeines Krankenhaus St. Georg, Abteilung
für Neurologie
Lohmühlenstraße
5
20099 Hamburg
Phone: 040/28902241
Fax: 040/2890 2971
Email: TRosenkranz@t-online.de
